CHRISTINA COFFIELD: Open Payments
NPI 1083290340 · GILLETTE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 116 payments from 13 companies in 2025. Trend: 2023 $1,103 · 2024 $1,455 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $511 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $301 |
| Alkermes, Inc. | 13 | $194 |
| Axsome Therapeutics, Inc. | 12 | $186 |
| Teva Pharmaceuticals USA, Inc. | 12 | $162 |
| Lundbeck LLC | 7 | $144 |
| Neurocrine BioSciences, Inc. | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: VRAYLAR, CAPLYTA, Auvelity, ARISTADA, REXULTI, INGREZZA, UZEDY, AUSTEDO XR.
Industry payments across WY — which companies pay providers there.
